Form 4/A for AGL agilon health, inc.
Accepted 2025-04-03 00:00:00 ET · period of report 2023-11-29 · accession 0001628280-25-016684 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2025-04-03 | 2025-04-01 | AGL | Schwaneke Jeffrey A. | CFO | A - Grant | $0.00 | +428.9K | 1.13M | +61% | $0 |
| DAI | 2025-04-03 | 2023-11-29 | AGL | Schwaneke Jeffrey A. | CFO | P - Purchase | $11.22 | +22.3K | 22.3K | New | +$250.2K |
| DA | 2025-04-03 | 2025-04-01 | AGL | Schwaneke Jeffrey A. | CFO | A - Grant | $0.00 | +673.1K | 673.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | A | A | 428,922 | $0.00 | 1,130,552 | D | — | — | (F3) Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. (F4) Includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date. (F5) Includes restricted stock units. |
| 2 | Common | Common Stock | 2023-11-29 | P | A | 22,300 | $11.22 | 22,300 | I By trust | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $11.12 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. (F2) This transaction was originally reported in November 2023 and is hereby amended to clarify that the shares were purchased by and are held in the Schwaneke Family Joint Spousal Trust. |
| 3 | Derivative | Options (Right to buy) | 2025-04-01 | A | A | 673,077 | $0.00 | 673,077 | D | $4.08 · — to 2035-04-01 | 673,077 Common Stock | (F6) Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. |